Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

CUSIP: 53566P109

Q4 2021 13F Holders as of 31 Dec 2021

Holder snapshot 7 signals
Share change
-2,164,354
Put/Call ratio
20%
SEC-reported price per share
$2.45
Number of holders
110
Value change
-$5,349,258
Number of buys
41
Open additional details 1 more signal available
Number of sells
49
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
250,425,788

Security key

53566P109

Report period

Q4 2021

Institutions

110

Top holders

10

Ownership snapshot

Top reported holders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
30 Sep 2021
13F Lead comparable stake: 14% Showing 1-6 of 15 holder rows.

Quick read

BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 14%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BROADWOOD CAPITAL INC's linked filing trail.
Comparable ownership Top 5
BROADWOOD CAPITAL INC 14%
BlackRock Finance, Inc. 3.4%
VANGUARD GROUP INC 2.4%
STATE STREET CORP 2.2%
Defender Capital, LLC. 1.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BROADWOOD CAPITAL INC
13F
Company
13F
14%
$85,694,000
34,005,379 shares
30 Sep 2021
BlackRock Finance, Inc.
13F
Company
13F
3.4%
$21,550,000
8,551,699 shares
30 Sep 2021
VANGUARD GROUP INC
13F
Company
13F
2.4%
$15,011,000
5,956,634 shares
30 Sep 2021
STATE STREET CORP
13F
Company
13F
2.2%
$13,755,000
5,458,451 shares
30 Sep 2021
Defender Capital, LLC.
13F
Company
13F
1.9%
$12,707,000
4,798,270 shares
30 Sep 2021
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
13F
0.94%
$5,900,000
2,341,514 shares
30 Sep 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
110
Shares
73,975,180
Rows available
110
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
106
Q4 2021 holders
110
Holder diff
4
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 value Q4 2021 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .